المؤلفون: Liru He, Yijun Zhang, Dong Chen, Yanjun Wang, Yonghong Li, Jun Wang, Hao Zeng, Yanxia Shi, Fangjian Zhou, Zhenyu Yang, Yuchao Ni, Zhiming Wu, Lijuan Jiang, Diwei Zhao

المصدر: BMC Cancer, Vol 21, Iss 1, Pp 1-9 (2021)
BMC Cancer

مصطلحات موضوعية: Oncology, Male, Cancer Research, medicine.medical_specialty, medicine.drug_class, Abiraterone Acetate, Kaplan-Meier Estimate, Dexamethasone, Prostate cancer, chemistry.chemical_compound, Prednisone, Surgical oncology, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Genetics, Clinical endpoint, medicine, Humans, Biochemical progression, Abiraterone, RC254-282, Aged, Proportional Hazards Models, Castration-resistant prostate cancer, Aged, 80 and over, business.industry, Drug Substitution, Research, Abiraterone acetate, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Corticosteroid switch, Middle Aged, Prostate-Specific Antigen, medicine.disease, Prognosis, Prostatic Neoplasms, Castration-Resistant, Treatment Outcome, chemistry, Disease Progression, Corticosteroid, business, Biomarkers, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::335181516bf1f0f3c00171d356d4b79b
https://doaj.org/article/ebb9e5a5d9e343c7a82320268d3b21d3

المؤلفون: Qiu Li, Dan Xie, Pengfei Zhang

المصدر: BMC Cancer, Vol 21, Iss 1, Pp 1-8 (2021)
BMC Cancer

مصطلحات موضوعية: Oncology, Male, Cancer Research, medicine.medical_specialty, Cost effectiveness, Cost-Benefit Analysis, Docetaxel, lcsh:RC254-282, 03 medical and health sciences, Prostate cancer, chemistry.chemical_compound, 0302 clinical medicine, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Genetics, Clinical endpoint, Enzalutamide, Medicine, Humans, 030212 general & internal medicine, Abiraterone, Survival analysis, health care economics and organizations, Cabazitaxel, business.industry, medicine.disease, Prognosis, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Survival Rate, Prostatic Neoplasms, Castration-Resistant, chemistry, Drug Resistance, Neoplasm, 030220 oncology & carcinogenesis, Androstenes, Taxoids, Cost-effectiveness, Quality-Adjusted Life Years, business, Progressive disease, medicine.drug, Research Article, Follow-Up Studies

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a23977dee8287187f90a961630ddea8a
https://doaj.org/article/3c54f32692d94f09bfac307387de553c

المؤلفون: Lixin Zhou, Baijun Dong, Wei Xue, Chenfei Chi, Liancheng Fan, Jiahua Pan, Yiran Huang, Yiming Gong, Jianjun Sha, Xun Shangguan, Yanqing Wang

المصدر: BMC Urology, Vol 18, Iss 1, Pp 1-8 (2018)
BMC Urology

مصطلحات موضوعية: Male, medicine.medical_specialty, Antineoplastic Agents, Hormonal, Urology, 030232 urology & nephrology, Abiraterone Acetate, Antineoplastic Agents, lcsh:RC870-923, Gastroenterology, Androgen deprivation therapy, 03 medical and health sciences, chemistry.chemical_compound, Prostate cancer, 0302 clinical medicine, Castration Resistance, Prednisone, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Chemotherapy-naive, Prospective Studies, Adverse effect, Prospective cohort study, Abiraterone, Aged, Retrospective Studies, business.industry, Response to previous therapy, Abiraterone acetate, General Medicine, Middle Aged, medicine.disease, Prognosis, lcsh:Diseases of the genitourinary system. Urology, Discontinuation, Metastatic castration-resistant prostate cancer, Prostatic Neoplasms, Castration-Resistant, Treatment Outcome, Reproductive Medicine, chemistry, 030220 oncology & carcinogenesis, business, medicine.drug, Follow-Up Studies, Research Article

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6e109b85915adb3d1df3df91ce30a97
http://link.springer.com/article/10.1186/s12894-018-0416-6